Content:
This Mutual Recognition Agreement (MRA) Sectoral Annex on Good Manufacturing Practices
(GMP) Compliance Certification pertaining to medicinal products/drugs has been developed by
the European Community (EC) and Canada to:
(a) enhance bilateral regulatory cooperation;
(b) establish mutual recognition for GMP compliance certification and acceptance of
Manufacturing Authorizations/Licences directly issued by the authorities designated
equivalent after the successful completion of a confidence building exercise;
(c) develop an infrastructure for on-going communications/consultations between Canada,
the European Commission, and the Regulatory Authorities of the EC Member States to
enable regulators to determine and maintain the equivalency of their GMP compliance
programmes.